AstraZeneca news in 2026: 31 dated events
The latest AstraZeneca event on this page is dated Nov 16, 2026. nationaltribune.com.au reported: AstraZeneca invests SEK 30 million in obesity research at KI.
PublicPharmaceutical Manufacturing10,000+ employeesastrazeneca.comLinkedIn
Get AstraZeneca's live signals in Claude or ChatGPT, or by API
What changed at AstraZeneca this week? Use Autobound signals for astrazeneca.com.- Dated events
- 31
- Last 90 days
- 31
- Latest
- Nov 16, 2026
Source: Autobound Signal API · 84 signals tracked for AstraZeneca · updated
News · latest 10
Latest AstraZeneca news
Showing 10 of 31 dated events. The Signal API returns all of them.
Get them with one API call- AstraZeneca invests SEK 30 million in obesity research at KIWith Karolinska Institutet
- AstraZeneca Cuts About 600 Marketing Jobs in Two Drug Businesses600 roles (reported)
- AstraZeneca Acquires Omniose to Strengthen Vaccine PipelineAstraZeneca has acquired Omniose, folding the early-stage biotechnology firm into its infectious diseases division.
- AstraZeneca Pharma India Reports 30% Revenue Growth, Crosses Rs 7,291 MnAstraZeneca Pharma India reported a 30 percent year-on-year growth in revenue from operations to Rs 7,291 million in Q2 FY2026-27.
- SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In FocusAstraZeneca is developing cancer vaccines internally alongside its investments in cell therapies.
- AstraZeneca India to Launch Datverzo as Q2 Revenue Rises 30%AstraZeneca Pharma India Limited plans to launch Datverzo (datopotamab deruxtecan) in India in November 2026.
- AstraZeneca India appoints new MD and Chennai centre headNaveen Krishna Yamarthi, Managing Director
- AstraZeneca profit jumps 23% as it unveils major savings planAstraZeneca is developing a weight-loss treatment to compete with Novo Nordisk and Eli Lilly.
- AstraZeneca India appoints new MD and Chennai centre headNaveen Krishna Yamarthi, Managing Director and Head of Global Innovation & Technology Centre
- AstraZeneca bags another US indication for Ultomiris with IgAN approvalAstraZeneca secured accelerated FDA approval for Ultomiris to treat primary immunoglobulin A nephropathy (IgAN).
Showing 10 of 31 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track AstraZeneca with the Signal API
One POST /v1/companies/enrich call with astrazeneca.com returns AstraZeneca news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"astrazeneca.com","signal_types":["news"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.
Same industry
News at related companies
Questions about AstraZeneca news
What is the latest news on AstraZeneca?
What is going on with AstraZeneca?
Is AstraZeneca laying off employees?
Page updated , the date of the newest row on this page.
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .